Your hepatic veins transport low-oxygen blood from your digestive tract to your heart and ultimately to your lungs. A blockage in your hepatic veins could lead to serious problems with your liver.

Hepatic arterial dilatation and wall thinning in non-cirrhotic patients with portal vein thrombosis provide pathologic evidence of hepatic arterial buffer response in the human liver.

IN recent years the technic of measuring the pressure in the wedged hepatic vein by means of catheterizing the hepatic vein has been utilized for assessing the level of the portal-vein pressure in ...

The Budd–Chiari syndrome is a heterogeneous group of disorders characterized by hepatic venous outflow obstruction at the level of the hepatic venules, the large hepatic veins, the inferior vena ...

A research team from France reported two cases of postoperative hepatic vein thrombosis after liver resection. They concluded that thrombosis of hepatic veins may occur after liver resection and ...

The underlying conditions favoring or precipitating hepatic vein or inferior vena cava thrombosis must be recognized and treated. This essential part of therapy is beyond the scope of this review ...

Evidence-based recommendations on melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver. This involves diverting ...

Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation is done under general anaesthesia. A high dose of melphalan chemotherapy is delivered directly into the ...

Hepatic vein thrombosis should be suspected when ascites, liver enlargement, and upper abdominal pain are simultaneously present, or when intractable ascites contrasts with mildly altered liver ...

Hepatic vein thrombosis (HVT) is an obstruction in the hepatic veins of the liver caused by a blood clot. This condition blocks the drainage system of your liver, impeding blood flow back to your ...

To determine the conversion to resectability in patients with unresectable liver metastases from colorectal cancer treated with hepatic arterial infusion (HAI) plus systemic oxaliplatin and irinotecan ...